-
- Scientists have created a bacterium that is resistant to all viruses.
- Using strands of RNA, researchers re-coded the organism so that when viruses try to invade, their replication instructions get all mixed around.
- The team hopes their new tech will eventually be used to create virus-resistant bacteria to be used in producing things like insulin.
Viruses are often incredibly hard to treat. We're certainly not strangers to that fact after the last few years. They're extremely adaptable and very hard to destroy, making them very dangerous to human health. Antivirals can sometimes help a little, but usually—you get a virus, you're stuck with it.
But what if instead of trying to treat these sneaky little beasts, we could stop them in their tracks before they even enter our cells? Create an organism that's basically immune to viruses right off the bat? Well, geneticists at Harvard claim they've done just that.
In a recent study, a team of researchers announced that they had made an E. coli bacterium immune to all viruses. Well, all they could test in the lab, anyway.
"We can't say it's fully virus-resistant," Akos Nyerges, genetics researcher and one of the authors of the study, said in a press release, "but so far, based on extensive laboratory experiments and computational analysis, we haven't found a virus that can break it."The researchers decided to take a "delete and trick" approach in the creation of their super-organism. They first went in and stripped the bacterium of three of its codons, which are little chunks of genetic code. And they didn't just pick at random—they carefully deleted the codons that viruses latch onto to begin replicating themselves.
So, problem solved, right? Wrong.
It turns out that viruses can bring their own versions of these codons into the cell and bypass the deletions altogether, kind of like bringing a power adapter on an international trip so you can plug your devices into wrong-shaped outlets.
So, in step two, the scientists got a little tricky with RNA. Specifically with tRNA, or transfer RNA. When a virus is trying, to begin the replication process, it basically plugs a strand of tRNA into a codon, and the codon "prints" out an amino acid. That process creates proteins.
But critically, if the codons "print" the wrong amino acid, nothing gets made. You just get a string of gibberish instructions that halt the viral duplication process in its tracks. So, the researcher team inserted strands of tRNA into the E. coli that would tell the codons brought in by the viruses to produce the wrong amino acids. Theoretically, the virus could bring in it's own tRNA too, but the researchers seem convinced that their tRNA strands win that fight.
With the codons now printing out completely wrong amino acids and the virus's replication instructions being turned into nonsense, the infection was stopped before it even got started. With that success under their belt, the team eventually wants to use their new gene tech to create strands of virus-resistant bacteria that can be used to produce things like insulin.
And who knows? Maybe someday, we'll be able to extend that tech to ourselves.
News
COVID-19 can wake up dormant viruses in the body, large study confirms
Virus reactivations by SARS-CoV-2 could worsen initial symptoms and increase risk of Long Covid. Early in the COVID-19 pandemic, scientists noticed that a SARS-CoV-2 infection can “wake up” other, dormant viruses already present in [...]
Scientists Discover the Brain May Enter a New Biological Phase Between 50 and 75
A single-cell study reveals major changes in immune cells, genome organization, and gene regulation within the aging human hippocampus, offering important insights into brain aging and dementias associated with age. Between roughly ages 50 [...]
Our books now available worldwide!
Online Sellers other than Amazon, Routledge, and IOPP Indigo Global Health Care Equivalency in the Age of Nanotechnology, Nanomedicine and Artifcial Intelligence Global Health Care Equivalency In The Age Of Nanotechnology, Nanomedicine And Artificial [...]
Unzipping the Code of Life: Scientists Pinpoint Where DNA First Opens
Researchers mapped where DNA first opens and how a helicase gate may release one strand as genome copying begins. Before a cell can divide, it must open its tightly wound DNA and begin copying the entire [...]
Scientists Tested an 8-Hour Eating Window and Found a Surprising Brain Benefit
Limiting the daily eating window may provide brain benefits beyond those associated with weight loss. Eating within a shorter daily window may provide cognitive benefits beyond those associated with weight loss alone, according to [...]
Focused Ultrasound Opens Blood-Brain Barrier to Treat Brain Cancer
Summary: A new study demonstrates that primary brain tumors (gliomas) are particularly receptive to targeted drug delivery using focused ultrasound (FUS) combined with microbubbles. The team developed a high-resolution MRI protocol to track blood-brain barrier [...]
AI’s promise and practical limits in drug discovery
AI tools are becoming increasingly common in early drug discovery, allowing scientists to analyse data and navigate large volumes of research. However, according to Dr Raminderpal Singh, turning that potential into consistent scientific workflows [...]
GHCE Concept
From the preface of the book Global Health Care Equivalency in the Age of Nanotechnology, Nanomedicine and Artificial Intelligence, Edited by Frank Boehm: Since the publication of my first book (Nanomedical Device and Systems [...]
Healthcare Headlines: Challenges and Advances in 2026
Health-related updates reveal financial adjustments by Universal Health Services due to Medicaid reimbursement uncertainties, significant pollution-linked health concerns from French-British oil firm Perenco in Congo, drug trial setbacks, potential restructuring at major medical firms, [...]
Scientists Discover the Brain Protein That Helps Alzheimer’s Spread Through the Brain
Scientists have identified a brain protein that may help Alzheimer’s spread, revealing a potential new target for slowing the disease’s progression. Alzheimer’s disease is closely linked to the accumulation of a toxic form of the protein [...]
How Immune Dysregulation Contributes to Psychiatric Disorders
Introduction Growing evidence suggests that disruptions in immune function may play an important role in the development and progression of psychiatric disorders. However, immune mechanisms probably contribute more strongly in some patients than others, [...]
Electrostatic Discharge Boosts Triboelectric Nanogenerator Current and Enables DC Output
Controlled electrical discharges could enable triboelectric nanogenerators to achieve higher peak currents, extending nano-enabled energy harvesting into chemical processing and self-powered sensing. Paper: Electrostatic discharge as a breakthrough strategy for triboelectric nanogenerators. A new review [...]
Swiss laboratory uses old drugs against rare diseases
Researchers at the University of Geneva are combing through collections of approved drugs to find new therapies for rare diseases – with some success. This approach is gaining traction around the world, while pharmaceutical [...]
Nanozyme Aptasensors Show Promise for Faster Food, Health, and Environmental Testing
By pairing robust artificial enzymes with highly selective aptamers, nanozyme aptasensors could help detect disease biomarkers, pathogens, and contaminants faster, but the review shows that real-world deployment still depends on overcoming matrix interference, biofouling, [...]
Paralyzed Man Feels Sensation Again With Brain Stimulation Device
Aneuroprosthetic system has allowed a man with paralysis to grasp and lift objects and feel touch again. The device helped 42-year-old Keith Thomas of Massapequa, New York, who was paralyzed from the chest down [...]
Global Cancer Cases Could Surge 67% by 2050, New Report Warns
New data reveal major geographic disparities and highlight the urgent need for global action on prevention, early detection, and equitable access to treatment. For roughly one in five people worldwide, cancer will become part [...]















